Connect with us

Business Partnerships

Peels Citrus CBD Gets $4 Million Investment from KarpReilly

Denis Mariti

Published

on

Peels Citrus CBD Gets $4 Million Investment from KarpReilly
- Ad -

Citrus CBD industries, Inc., a CBD startup, has introduced its first global CBD brand. The CBD brand is engineered from oranges under Chris Hetherington's leadership. Chris Hetherington is the company’s CEO and Founder, a Yale Alumni, and an 11-year NFL veteran. The company has announced its latest investment, in which they secured a $4 million deal with KarpReilly, LLC.

KarpReilly is a private investment firm based in Greenwich, CT boasting a comprehensive portfolio of growing consumer brands containing notable natural products, foods, and beverages such as Wilde, KeVita, LIFEAID, Spindrift, and Salt & Straw.

CEO Chris Hetherington is enthusiastic about this latest investment from KarpReilly. Chris and his team believe that they will realize their goal of becoming the most trusted CBD brand through the partnership. KarpReilly has earned a solid reputation and enough resources to help startups such as Citrus CBD achieve their goals.

Peels is a pioneering CBD product line by Citrus CBD crafted uniquely using all-natural and “nature-identical” CBD. It’s proven by science to have the same molecular formula as CBD from the cannabis plant and offers outstanding holistic effects while ensuring optimum safety and quality. This CBD product is created from citrus peels-sourced terpenes and doesn’t contain any THC content or toxic elements.

Peels products are unbeatable for taste and purity and are the perfect solution for those looking for reliably crafted, safe, and efficient CBD products. Since they offer premium cannabinoids from non-cannabis and non-hemp sources, they make it possible for consumers to experience the benefits of CBD uniquely.

Peels are formulated to match the ever-growing demand for CBD without exposing users to cannabis and hemp CBD products' uncertainty. Peels work with a highly approachable brand and exclusive product designed to help them stand out in the competitive CBD space and market. According to Drew Skolnik, KarpReilly’s Principal, the partnership with Chris and his team will allow them to work and explore more markets. Per the official website,

“This means it's molecularly identical to CBD produced by the cannabis plant and has the same holistic effects, but is produced at superior quality, safety, and scale.”

Peels’ management team is a blend of world-class and experienced business development, sales, operations, and marketing executives, who wouldn’t mind tapping into the benefits of the new deal.

About Peels

Peels is a Los-Angeles-based CBD startup that is science and data-driven and commits to delivering the finest wellness products. The company’s commitment and passion for developing highly innovative and quality products will see them sail higher and deeper into the potentially profitable CBD markets that are rarely tapped.

About KarpReilly

KarpReilly, LLC is a privately owned investment company launched by Chris Reilly and Allan Karp to offer mid-size and small companies a shoulder to lean on, helping them achieve their target goals vision. The company currently manages finances and partners with capital pledges of over $500 million. Having been around serving its target customers in the last 15 years, KarpReilly's principals have successfully invested and helped over 40 companies to grow.

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.